Platelet receptors and their role in diseases

Clinical Chemistry and Laboratory Medicine

Volumn 41, Issue 3, 2003, Pages 253-260

  Clemetson, Kenneth J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Bernard Soulier syndrome; Glanzmann's thrombasthenia; Idiopathic thrombocytopenia purpura; Platelet receptors; Receptor polymorphisms

Indexed keywords

AUTOANTIBODY; CD36 ANTIGEN; CLOPIDOGREL; FIBRINOGEN RECEPTOR; INTEGRIN; PURINE P2Y RECEPTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE RECEPTOR; TICLOPIDINE; VON WILLEBRAND FACTOR;

ASTHMA; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; BERNARD SOULIER DISEASE; BLEEDING DISORDER; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DISEASE PREDISPOSITION; DRUG TARGETING; GENE MUTATION; GLANZMANN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA; VON WILLEBRAND DISEASE;

ANTIGENS, HUMAN PLATELET; AUTOIMMUNE DISEASES; BLOOD PLATELET DISORDERS; CARDIOVASCULAR DISEASES; HUMANS; PLATELET MEMBRANE GLYCOPROTEINS; POLYMORPHISM, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS; PURPURA;

EID: 0037256871     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2003.039     Document Type: Review

References (72)

1. Lopez JA, Chung DW, Fujikawa K, Hagen FS, Papayannopoulou T, Roth GJ. Cloning of the alpha chain of human platelet glycoprotein Ib: a transmembrane protein with homology to leucine-rich alpha 2-glycoprotein. Proc Natl Acad Sci USA 1987; 84:5615-9.
2. Lopez JA, Chung DW, Fujikawa K, Hagen FS, Davie EW, Roth GJ. The alpha and beta chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence. Proc Natl Acad Sci USA 1988; 85:2135-9.
3. Hickey MJ, Williams SA, Roth GJ. Human platelet glycoprotein IX: an adhesive prototype of leucine-rich glycoproteins with flank-center-flank structures. Proc Natl Acad Sci USA 1989; 86:6773-7.
4. Lanza, F, Morales M, de La Salle C, Cazenave JP, Clemetson KJ, Shimomura T, et al. Cloning and characterization of the gene encoding the human platelet glycoprotein V. A member of the leucine-rich glycoprotein family cleaved during thrombin-induced platelet activation. J Biol Chem 1993; 268:20801-7.
5. Kahn ML, Diacovo TG, Bainton DF, Lanza F, Trejo J, Coughlin SR. Glycoprotein V-deficient platelets have undiminished thrombin responsiveness and do not exhibit a Bernard-Soulier phenotype. Blood 1999; 94:4112-21.
6. Ramakrishnan V, Reeves PS, DeGuzman F, Deshpande U, Ministri-Madrid K, DuBridge RB, et al. Increased thrombin responsiveness in platelets from mice lacking glycoprotein V. Proc Natl Acad Sci USA 1999; 96:13336-41.
7. Ni H, Ramakrishnan V, Ruggeri ZM, Papalia JM, Phillips DR, Wagner DD. Increased thrombogenesis and embolus formation in mice lacking glycoprotein V. Blood 2001; 98:368-73.
8. Lopez JA, Andrews RK, Afshar-Kharghan V, Berndt MC. Bernard-Soulier syndrome. Blood 1998; 91:4397-418.
9. Nurden AT. Inherited abnormalities of platelets. Thromb Haemost 1999; 82:468-80.
10. Miller JL, Lyle VA, Cunningham D. Mutation of leucine-57 to phenylalanine in a platelet glycoprotein Ibα leucine tandem repeat occurring in patients with an autosomal dominant variant of Bernard-Soulier disease. Blood 1992; 79: 439-46.
11. Jamieson GA, Okumura T. Reduced thrombin binding and aggregation in Bernard-Soulier platelets. J Clin Invest 1978; 61:861-4.
12. Bevers EM, Comfurius P, Nieuwenhuis HK, Levy-Toledano S, Enouf J, Belluci S, et al. Platelet prothrombin converting activity in hereditary disorders of platelet function. Br J Haematol 1986; 63:335-45.
13. De Candia E, Hall SW, Rutella S, Landolfi R, Andrews RK, De Cristofaro R. Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of PAR-1 on intact platelets. J Biol Chem 2001; 276:4692-8.
14. Li CQ, Vindigni A, Sadler JE, Wardell MR. Platelet glycoprotein Ibα binds to thrombin anion-binding exosite II inducing allosteric changes in thrombin's activity. J Biol Chem 2000; 175:7539-46.
15. Dormann D, Clemetson KJ, Kehrel BE. The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity. Blood 2000; 96:2469-78.
16. Ware J, Russell SR, Marchese P, Murata M, Mazzucato M, De Marco L, et al. Point mutation in a leucine-rich repeat of platelet glycoprotein Ibα resulting in the Bernard-Soulier syndrome. J Clin Invest 1993; 92:1213-20.
17. Ulsemer P, Lanza F, Baas MJ, Schwartz A, Ravanat C, Briquel ME, et al. Role of the leucine-rich domain of platelet GPIbα in correct post-translational processing - the Nancy I Bernard-Soulier mutation expressed on CHO cells. Thromb Haemost 2000; 84:104-11.
18. Ludlow LB, Schick BP, Budarf ML, Driscoll DA, Zackai EH, Cohen A, et al. Identification of a mutation in a GATA binding site of the platelet glycoprotein Ibβ promoter resulting in the Bernard-Soulier syndrome. J Biol Chem 1996; 271:22076-80.
19. Uff S, Clemetson JM, Harrison T, Clemetson KJ, Emsley J. Crystal structure of the platelet glycoprotein Ibα N-terminal domain reveals an unmasking mechanism for receptor activation. J Biol Chem 2002; 277:35657-63.
20. Glanzmann E. Hereditäre hämorrhahagische Thrombasthenie: Ein Beitrag zur Pathologie der Blutplättchen. J Kinderkr 1918; 88:113-41.
21. Nurden AT, Caen JP. An abnormal platelet glycoprotein pattern in three cases of Glanzmann's thrombasthenia. Br J Haematol 1974; 28:253-60.
22. Phillips DR, Jenkins CS, Luscher EF, Larrieu M. Molecular differences of exposed surface proteins on thrombasthenic platelet plasma membranes. Nature 1975; 257:599-600.
23. French DL, Seligsohn U. Platelet glycoprotein IIb/IIIa receptors and Glanzmann's thrombasthenia. Arterioscler Thromb Vasc Biol 2000; 20:607-10.
24. 3 based on electron cryomicroscopy and X-ray crystallography. Proc Natl Acad Sci USA 2002; 99:14059-64.
25. 3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: comparison with other mutations causing ligand-binding defects. Blood 2003. In press.
26. 3 complex that retains partial function in a novel form of type II Glanzmann thrombasthenia. Thromb Haemost 1998; 80:42-8.
27. 3 complex that binds fibrin but not fibrinogen. Blood 2000; 96:161-9.
28. Cattaneo M, Lecchi A, Randi AM, McGregor JL, Mannucci PM. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood 1992; 80:2787-96.
29. Nurden P, Savi P, Heilmann E, Bihour C, Herbert JM, Maffrand JP, et al. An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function. J Clin Invest 1995; 95:1612-22.
30. Zhang FL, Luo L, Gustafson E, Lachowicz J, Smith M, Qiao X, et al. ADP is the cognate ligand for the orphan G-protein-coupled receptor SP1999. J Biol Chem 2001; 276: 8608-15.
31. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001; 409:202-7.
32. Nieuwenhuis HK, Akkerman JW, Houdijk WP, Sixma JJ. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 1985; 318:470-2.
33. Kehrel B, Balleisen L, Kokott R, Mesters R, Stenzinger W, Clemetson KJ, et al. Deficiency of intact thrombospondin and membrane glycoprotein Ia in platelets with defective collagen-induced aggregation and spontaneous loss of disorder. Blood 1988; 71:1074-8.
34. 2 integrin subunit-deficient mouse: a multifaceted phenotype including defects of branching morphogenesis and hemostasis. Am J Pathol 2002; 161:337-44.
35. 1 integrin is essential for platelet interaction with collagen. EMBO J 2001; 20:2120-30.
36. 3 integrins. J Clin Invest 2003; 111:51-60.
37. Clemetson JM, Polgar J, Magnenat E, Wells TN, Clemetson KJ. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcαR and the natural killer receptors. J Biol Chem 1999; 274:29019-24.
38. Sugiyama T, Okuma M, Ushikubi F, Sensaki S, Kanaji K, Uchino H. A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. Blood 1987; 69:1712-20.
39. Yamamoto N, Ikeda H, Tandon NN, Herman J, Tomiyama Y, Mitani T, et al. A platelet membrane glycoprotein (GP) deficiency in healthy blood donors: Naka-platelets lack detectable GPIV (CD36). Blood 1990; 76:1698-703.
40. Lee K, Godeau B, Fromont P, Plonquet A, Debili N, Bachir D, et al. CD36 deficiency is frequent and can cause platelet immunization in Africans. Transfusion 1999; 39:873-9.
41. Abumrad NA, el-Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 1993; 268:17665-8.
42. Kashiwagi H, Tomiyama Y, Honda S, Kosugi S, Shiraga M, Nagao N, et al. Molecular basis of CD36 deficiency. Evidence that a 478C→T substitution (proline90→serine) in CD36 cDNA accounts for CD36 deficiency. J Clin Invest 1995; 95:1040-6.
43. Niessner H, Clemetson KJ, Panzer S, Mueller-Eckhardt C, Santoso S, Bettelheim P. Acquired thrombasthenia due to GPIIb/IIIa-specific platelet autoantibodies. Blood 1986; 68: 571-6.
44. Stricker RB, Wong D, Saks SR, Corash L, Shuman MA. Acquired Bernard-Soulier syndrome. Evidence for the role of a 210,000-molecular weight protein in the interaction of platelets with von Willebrand factor. J Clin Invest 1985; 76:1274-8.
45. Kelton JG. Heparin-induced thrombocytopenia: an overview. Blood Rev 2002; 16:77-80.
46. Greinacher A. Heparin-induced thrombocytopenia-pathogenesis and treatment. Thromb Haemost 1999; 82 Suppl 1:148-56.
47. Farner B, Eichler P, Kroll H, Greinacher A. A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia. Thromb Haemost 2001; 85:950-7.
48. Youssefian T, Drouin A, Masse JM, Guichard J, Cramer EM. Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood 2002; 99:4021-9.
49. Newman PJ, Derbes RS, Aster RH. The human platelet alloantigens, PIA1 and PIA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 1989; 83:1778-81.
50. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996; 334:1090-4.
51. 3 enhances outside-in signaling and adhesive functions. J Clin Invest 2000; 105:793-802.
52. Andrioli G, Minuz P, Solero P, Pincelli S, Ortolani R, Lussignoli S, et al. Defective platelet response to arachidonic acid and thromboxane A(2) in subjects with PI(A2) polymorphism of beta(3) subunit (glycoprotein IIIa). Br J Haematol 2000; 110:911-8.
53. Reiner AP, Schwartz SM, Kumar PN, Rosendaal FR, Pearce RM, Aramaki KM, et al. Platelet glycoprotein IIb polymorphism, traditional risk factors and non-fatal myocardial infarction in young women. Br J Haematol 2001; 112:632-6.
54. Bottiger C, Kastrati A, Koch W, Mehilli J, Seidl H, Schomig K, et al. HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction. Thromb Haemost 2000; 83:559-62.
55. b are associated with a single amino acid polymorphism on glycoprotein Ia (integrin subunit α2). J Clin Invest 1993; 92:2427-32.
56. 2 subunit of VLA-2). Br J Haematol 1994; 86:671-4.
57. Moshfegh K, Wuillemin WA, Redondo M, Lammle B, Beer JH, Liechti-Gallati S, Meyer BJ. Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: a case-control study. Lancet 1999; 353:351-4.
58. Santoso S, Kunicki TJ, Kroll H, Haberbosch W, Gardemann A. Association of the platelet glycoprotein Ia C807T gene polymorphism with nonfatal myocardial infarction in younger patients. Blood 1999; 93:2449-53.
59. 1 might be a genetic risk factor for the development of stroke in younger patients. Blood 1999; 93:3583-6.
60. Kroll H, Gardemann A, Fechter A, Haberbosch W, Santoso S. The impact of the glycoprotein Ia collagen receptor subunit A1648G gene polymorphism on coronary artery disease and acute myocardial infarction. Thromb Haemost 2000; 83:392-6.
61. von Beckerath N, Koch W, Mehilli J, Bottiger C, Schomig A, Kastrati A. Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting. Blood 2000; 95:3297-301.
62. 2-807 in malignant arrhythmia in coronary artery disease. Thromb Res 2000; 98:281-6.
63. Reiner AP, Kumar PN, Schwartz SM, Longstreth WT Jr, Pearce RM, Rosendaal FR, et al. Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke 2000; 31:1628-33.
64. 1 is associated with increased risk of cardiovascular mortality in high-risk women. Circulation 2000; 102:1645-50.
65. Kuijpers RW, Faber NM, Cuypers HT, Ouwehand WH, von dem Borne AE. NH2-terminal globular domain of human platelet glycoprotein Ib alpha has a methionine 145/threonine 145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens. J Clin Invest 1992; 89: 381-4.
66. Lopez JA, Ludwig EH, McCarthy BJ. Polymorphism of human glycoprotein Ibα results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycopeptide region. Structure/function implications. J Biol Chem 1992; 267:10055-61.
67. Sonoda A, Murata M, Ikeda Y, Fukuuchi Y, Watanabe K. Stroke and platelet glycoprotein Ibα polymorphisms. Thromb Haemost 2001; 85:572-3.
68. Yamada S, Akita H, Kanazawa K, Ishida T, Hirata K, Ito K, et al. T102C polymorphism of the serotonin (5-HT) 2A receptor gene in patients with non-fatal acute myocardial infarction. Atherosclerosis 2000; 150:143-8.
69. Tonelli R, Strippoli P, Grossi A, Savoia A, Iolascon A, Savino M, et al. Hereditary thrombocytopenia due to reduced platelet production-report on two families and mutational screening of the thrombopoietin receptor gene (c-mpl). Thromb Haemost 2000; 83:931-6.
70. Warmerdam PA, van de Winkel JG, Gosselin EJ, Capel PJ. Molecular basis for a polymorphism of human Fc gamma receptor II (CD32). J Exp Med 1990; 172:19-25.
71. 1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system. Blood 1999; 93:3578-82.
72. Massberg S, Brand K, Gruner S, Page S, Muller E, Muller I, et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002; 196: 887-96.